Stocksigma LogoStocksigma Logo

Crisil Assigns Strong ESG Ratings to Cohance Lifesciences

Crisil ESG Ratings & Analytics Limited has voluntarily assigned an ESG rating of "Crisil ESG 61 (Strong)" and a Core ESG rating of "Crisil Core ESG 67

Crisil Assigns Strong ESG Ratings to Cohance Lifesciences

Cohance Lifesciences Ltd 路 Others (Uncategorized) 路 06 Oct 2026, 8:54 pm

Crisil Assigns Strong ESG Ratings to Cohance Lifesciences Crisil ESG Ratings & Analytics Limited has voluntarily assigned an ESG rating of "Crisil ESG 61 (Strong)" and a Core ESG rating of "Crisil Core ESG 67 (Strong)" to Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited) on 6th Oct'26. The ratings were independently evaluated based on publicly available information, with no formal engagement initiated by the company.

Original exchange filing (PDF)

More announcements from Cohance Lifesciences Ltd

All Cohance Lifesciences Ltd announcements